Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
Deepa Valvi1, David M Mannino1,2, Hana Müllerova3, Ruth Tal-Singer41Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, KY, USA; 2Department of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky Colleg...
Main Authors: | Mannino DM, Müellerova H, Valvi D, Tal-Singer R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/fibrinogen-chronic-obstructive-pulmonary-disease-copd-and-outcomes-in--a9432 |
Similar Items
-
Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): Rationale and protocol
by: M. Fisk, et al.
Published: (2013-11-01) -
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes
by: Aryal S, et al.
Published: (2014-10-01) -
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
by: Vogelmeier Claus, et al.
Published: (2010-06-01) -
Defining and targeting health disparities in chronic obstructive pulmonary disease
by: Pleasants RA, et al.
Published: (2016-10-01) -
Approach to: Chronic obstructive pulmonary disease (COPD)
by: Alexander Ni
Published: (2020-10-01)